Blogs

AUA Urges CMS to Prohibit Step Therapy in Medicare Advantage Plans

By Policy and Advocacy Brief posted 05-23-2022 14:47

  

On May 20, the AUA joined the Step Therapy Coalition in asking the Centers for Medicare & Medicaid Services (CMS) to reinstate the step therapy prohibition in Medicare Advantage (MA) plans for Part B drugs as described in the September 17, 2012 HPMS memo Prohibition on Imposing Mandatory Step Therapy for Access to Part B Drugs and Services. The Step Therapy Coalition highlighted concerns that, if step therapy remains permissible, patients will continue to see reductions in access to care.

The AUA remains committed to reducing regulatory burdens in an effort to promote practice sustainability during the COVID-19 public health emergency and beyond. A copy of the letter is attached.

05_20_2022_CMS_Letter_on_Step_Therapy_in_Medicare_Advantage_Plans.pdf

0 comments
6 views

Permalink